Taminiau JA - Search Results

1

Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.

Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Jaspers GJ, et al. Among authors: taminiau ja. Inflamm Bowel Dis. 2006 Sep;12(9):831-6. doi: 10.1097/01.mib.0000232470.00703.67. Inflamm Bowel Dis. 2006. PMID: 16954801

2

Treatment of inflammatory bowel disease in childhood: best available evidence.

Escher JC, Taminiau JA, Nieuwenhuis EE, Büller HA, Grand RJ. Escher JC, et al. Among authors: taminiau ja. Inflamm Bowel Dis. 2003 Jan;9(1):34-58. doi: 10.1097/00054725-200301000-00006. Inflamm Bowel Dis. 2003. PMID: 12656136 Review.

3

Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.

de Ridder L, Weersma RK, Dijkstra G, van der Steege G, Benninga MA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC. de Ridder L, et al. Among authors: taminiau ja. Inflamm Bowel Dis. 2007 Sep;13(9):1083-92. doi: 10.1002/ibd.20171. Inflamm Bowel Dis. 2007. PMID: 17476680

4

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.

de Ridder L, Escher JC, Bouquet J, Schweizer JJ, Rings EH, Tolboom JJ, Houwen RH, Norbruis OF, Derkx BH, Taminiau JA. de Ridder L, et al. Among authors: taminiau ja. J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):46-52. doi: 10.1097/00005176-200407000-00010. J Pediatr Gastroenterol Nutr. 2004. PMID: 15187780

5

Infliximab as first-line therapy in severe pediatric Crohn disease.

de Ridder L, Benninga MA, Taminiau JA, Hommes DW. de Ridder L, et al. Among authors: taminiau ja. J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):388-90. doi: 10.1097/01.mpg.0000226369.31956.bf. J Pediatr Gastroenterol Nutr. 2006. PMID: 16954965 No abstract available.

6

Treatment of inflammatory bowel disease in childhood.

Escher JC, Taminiau JA. Escher JC, et al. Among authors: taminiau ja. Scand J Gastroenterol Suppl. 2001;(234):48-50. doi: 10.1080/003655201753265109. Scand J Gastroenterol Suppl. 2001. PMID: 11768561

7

[Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].

de Ridder L, Escher JC, Taminiau JA. de Ridder L, et al. Among authors: taminiau ja. Ned Tijdschr Geneeskd. 2002 Oct 5;146(40):1879-83. Ned Tijdschr Geneeskd. 2002. PMID: 12395595 Dutch.

8

Rectal bleeding in children: endoscopic evaluation revisited.

de Ridder L, van Lingen AV, Taminiau JA, Benninga MA. de Ridder L, et al. Among authors: taminiau ja. Eur J Gastroenterol Hepatol. 2007 Apr;19(4):317-20. doi: 10.1097/MEG.0b013e328080caa6. Eur J Gastroenterol Hepatol. 2007. PMID: 17353696

9

Infliximab use in children and adolescents with inflammatory bowel disease.

de Ridder L, Benninga MA, Taminiau JA, Hommes DW, van Deventer SJ. de Ridder L, et al. Among authors: taminiau ja. J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):3-14. doi: 10.1097/MPG.0b013e31803e171c. J Pediatr Gastroenterol Nutr. 2007. PMID: 17592358 Review.

10

The incidence of pediatric inflammatory bowel disease in the Netherlands: 1999-2001.

van der Zaag-Loonen HJ, Casparie M, Taminiau JA, Escher JC, Pereira RR, Derkx HH. van der Zaag-Loonen HJ, et al. Among authors: taminiau ja. J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):302-7. doi: 10.1097/00005176-200403000-00014. J Pediatr Gastroenterol Nutr. 2004. PMID: 15076631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters